publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
microbiolog
respiratori
system
infect
http
dx
variant
human
bocaviru
caus
respiratori
infect
primat
human
belong
famili
parvovirida
subfamili
parvovirina
genu
bocaparvoviru
discov
origin
tobia
alland
team
repres
togeth
strain
gorilla
bocaviru
speci
primat
bocaparvoviru
discoveri
one
among
seri
viru
discoveri
first
decad
millennium
base
novel
viru
discoveri
system
develop
order
reduc
consider
number
case
clinic
diagnosi
respiratori
infect
could
confirm
detect
pathogen
follow
initi
descript
viru
huge
number
clinic
studi
case
report
publish
supplement
basic
research
report
unfortun
hbov
research
still
reli
clinic
studi
case
report
accompani
cell
cultur
studi
major
sourc
inform
hbov
biolog
far
anim
model
identifi
human
bocaviru
hbov
initi
discov
clinic
sampl
respiratori
tract
children
suffer
respiratori
infect
unknown
etiolog
date
hbov
fourth
detect
respiratori
viru
still
anim
model
broadli
convert
cell
cultur
avail
koch
modifi
postul
yet
complet
fulfil
nevertheless
hbov
second
parvoviru
capabl
infect
human
potenti
caus
clinic
diseas
hbov
discov
parvoviru
sole
human
parvoviru
hardli
cultur
vitro
cell
cultur
like
strongli
depend
optim
cell
cycl
phase
latter
fact
hamper
develop
potent
specif
antivir
tenac
studi
develop
disinfect
activ
human
parvovirus
surrog
pathogen
anim
pathogen
use
discoveri
hbov
led
coupl
molecular
find
major
gener
interest
human
parvoviru
biolog
clinic
within
primari
cell
cultur
product
replic
human
bocaviru
possibl
identifi
hbov
transcriptom
includ
splice
variant
viral
rna
cell
cultur
display
first
time
tool
investig
human
parvoviru
natur
infecti
surround
enabl
follow
studi
molecular
biolog
human
parvovirus
gener
hbov
particular
unfortun
primari
cell
cultur
enabl
hbov
growth
vitro
expens
requir
highli
special
laboratori
errorpron
cell
cultur
thu
avail
technolog
rather
limit
coupl
laboratori
worldwid
turn
stumbl
block
research
search
broadli
convert
replic
system
group
jianm
qiu
kansa
made
signific
step
forward
establish
plasmid
base
repliconlik
system
group
identifi
addit
rna
speci
transcrib
hbov
replic
cycl
system
base
plasmid
contain
complet
publish
hbov
sequenc
flank
itrregion
adenoassoci
viru
aav
itrregion
termin
repeat
contain
palindrom
sequenc
form
hairpinlik
structur
turn
requir
replic
parvovirus
accord
socal
roll
hairpin
mechan
replic
although
hairpinlik
structur
hbov
yet
describ
time
postul
also
hbov
genom
flank
structur
hbov
replic
genom
roll
hairpin
mechan
although
assumpt
exclus
base
phylogenet
analog
conclus
rather
experiment
evid
theori
roll
hairpin
replic
result
progeni
genom
occur
equal
amount
polar
packag
viral
genom
depend
addit
factor
almost
four
decad
postul
parvovirus
replic
accord
mechan
although
replic
model
sole
base
experiment
data
obtain
research
rodent
parvovirus
model
character
termin
hairpin
depend
selfprim
initi
viral
genom
replic
concatemer
replic
intermedi
headtohead
tailtotail
replic
intermedi
base
earli
public
postul
model
natur
replic
model
becam
dogma
field
parvovirolog
deem
true
parvovirus
interestingli
imposs
identifi
genom
polar
clinic
sampl
contain
hbov
infect
cell
therebi
nasba
analys
reveal
hbov
strain
packag
neg
strand
genom
minor
also
packag
plu
strand
observ
compat
anoth
replic
mechan
known
roll
circl
replic
coupl
systemat
pcrbase
analys
perform
test
hypothesi
roll
circl
replic
may
occur
hbov
infect
deciph
unknown
termin
hairpin
approach
identifi
dna
sequenc
contain
headtotail
genom
fragment
link
newli
identifi
linker
stretch
partial
high
homolog
minut
viru
canin
mvc
itr
itr
bovin
parvoviru
recent
shown
sequenc
like
repres
miss
termin
hairpin
like
structur
like
viru
origin
transmit
zoonosi
fig
despit
identifi
termin
sequenc
clinic
sampl
also
cell
cultur
lack
selfprim
activ
hbovgenom
also
lack
intermedi
typic
roll
hairpin
replic
observ
instead
sampl
contain
headtotail
structur
sever
group
publish
similar
observ
tackl
dogma
parvoviru
replic
therefor
import
know
headtotail
episom
form
hbov
differ
formerli
describ
circular
parvovir
episom
shown
consist
circular
close
genom
dimer
headtohead
tailtotail
orient
although
role
linker
sequenc
headtotail
junction
remain
unclear
find
surpris
support
hypothesi
hbov
replic
differ
nonhuman
parvovirus
possibl
initi
roll
circl
mechan
least
altern
rout
replic
base
newli
identifi
sequenc
structur
put
termin
repeat
hbov
genom
predict
silico
beyond
kansa
group
develop
true
fulllength
vector
clone
hbov
transfect
cell
produc
recombin
wild
type
human
bocaviru
turn
infecti
differenti
cell
cell
deriv
patient
cystic
fibrosi
grown
monolay
cultur
chang
cultur
media
differenti
polar
respiratori
epitheli
structur
turn
support
hbov
replic
novel
cell
cultur
give
rais
hypothesi
hbov
true
seriou
pathogen
induc
remark
cytopath
effect
polar
cell
line
turn
compat
assumpt
clinic
symptom
hbov
infect
caus
tissu
base
sequenc
analys
especi
termin
sequenc
zoonot
event
like
contain
genom
structur
highli
conserv
canin
minut
viru
bovin
parvoviru
damag
due
viral
replic
therebi
infect
model
harbor
surpris
featur
hint
altern
replic
human
bocavirusif
fulllength
hbov
plasmid
contain
hairpin
sequenc
transfect
cell
infecti
progeni
virion
produc
although
base
roll
hairpin
model
process
must
imposs
free
hairpin
sequenc
believ
essenti
replic
contrast
plasmid
flank
vector
backbon
sequenc
replic
possibl
although
helper
plasmid
requir
known
dependovirus
simpl
observ
strongli
contradict
model
roll
hairpin
replic
turn
favour
replic
model
known
circular
dna
exampl
roll
circl
replic
natur
infect
would
produc
headtotail
concatem
furthermor
clinic
observ
give
rais
hypothesi
hbov
replic
trigger
influenc
human
herpesvirus
cmv
herp
simplex
viru
context
noteworthi
herpesvirus
especi
hsv
capabl
initi
roll
circl
replic
mechan
replic
tran
shown
circular
doubl
strand
genom
therebi
herpesvirus
may
either
act
trigger
arrest
host
cell
transit
sphase
cell
cycl
could
directli
interact
hbov
dna
support
replic
herpesvir
replic
enzym
latter
appear
like
headtotail
intermedi
featur
roll
circl
replic
may
initi
coupl
virus
includ
human
herpesvirus
type
type
virus
eg
aav
turn
abl
act
helper
virus
parvovir
subclass
dependovirus
requir
helper
virus
replic
recent
clinic
case
observ
hbov
infect
appear
depend
coinfect
corepl
human
herpesviru
type
case
hbov
infect
persist
immun
diseas
termin
antivir
therapi
cidofovir
direct
key
observ
lead
assumpt
hbov
either
sensit
cidofovir
possibl
roll
circl
hbov
replic
trigger
turn
would
explain
high
frequenc
coinfect
observ
case
hbov
two
sever
case
respiratori
failur
adult
associ
hbov
infect
herpesviru
coinfect
histori
lung
fibrosi
like
dedic
presenc
chronic
hbov
infect
indic
headtotail
structur
could
episom
reservoir
enabl
viru
persist
postul
kapoor
cowork
may
specul
whether
persist
hbov
episom
lung
patient
analog
hbv
infect
episom
cccdna
persist
infect
cell
cell
target
immun
respons
subject
apoptosi
chronic
state
frequent
goe
ahead
mild
inflamm
subclin
final
could
induc
fibrosi
could
led
mild
chronic
inflamm
eventu
result
fibrosi
lung
could
easili
compens
liver
context
put
chronic
hbov
infect
persist
hbov
subclin
level
thu
appear
possibl
hbov
could
directli
indirectli
interact
immun
system
contribut
chronic
lung
diseas
idiopath
lung
fibrosi
anoth
recent
detect
novel
featur
hbov
express
nonstructur
protein
conclud
previou
knowledg
parvoviru
replic
studi
shen
et
al
shown
besid
three
novel
protein
name
express
viral
replic
believ
crucial
role
viral
life
cycl
like
respiratori
pathogen
except
sarsand
merscoronaviru
caus
respiratori
infect
distribut
worldwid
detect
patient
sever
region
contin
howev
unlik
virus
known
peak
season
autumn
winter
hbov
infect
peak
seem
restrict
season
although
rout
transmiss
yet
systemat
investig
wide
accept
transmiss
hbov
like
occur
smear
droplet
infect
aerosol
nasal
oral
uptak
describ
major
common
cold
virus
transmiss
rout
pass
airway
excret
could
also
happen
via
gastrointestin
rout
hbov
also
shed
stool
fig
hbov
seropreval
high
reach
children
age
year
seropreval
remain
high
adult
decreas
european
adult
antibodi
hbov
strain
deplet
thu
patient
long
term
immun
could
gener
support
assumpt
viru
abl
persist
could
also
reinfect
elderli
patient
surprisingli
dna
also
detect
blood
blood
product
healthi
chines
blood
donor
lower
seroposit
compar
afor
mention
cohort
infect
clinic
indistinguish
respiratori
infect
sole
proven
molecular
assay
spectrum
hbov
infect
rang
asymptomat
mild
upper
respiratori
infect
seriou
life
threaten
lower
respiratori
tract
infect
age
group
immun
respons
hbov
start
igm
respons
follow
format
igg
life
long
immun
gener
least
patient
due
origin
antigen
sin
abl
infect
central
nervou
system
identifi
put
caus
idiopath
lung
fibrosi
support
fact
set
profibrot
cytokin
upregul
hbov
infect
adult
hbov
depend
upregul
confirm
cell
cultur
wherea
hbov
induc
clear
respons
furthermor
hbov
depend
regul
cytokin
includ
subset
cytokin
known
involv
sever
cancerassoci
pathway
support
hypothesi
hbov
may
associ
long
term
diseas
even
cancerogenesi
although
hypothesi
requir
prospect
studi
hbov
dna
detect
lungand
colorect
tumor
detect
hbov
dna
eventu
combin
persist
describ
besid
detect
normal
lung
tissu
lungand
colorect
tumor
tissu
tonsil
myocardium
may
affect
tissu
yet
test
hbovposit
lung
fibrosi
especi
idiopath
lung
fibrosi
ipf
character
domin
immun
respons
affect
tissu
review
respons
lung
accompani
increas
express
level
follow
increas
levelsbesid
othersof
tarc
rant
moreov
fibrosi
relat
express
tnf
worth
mention
neutral
tarc
lead
reduct
fibrosi
anim
model
addit
elev
ratio
also
characterist
fibrosi
previous
discuss
marker
ipf
moreov
far
uniqu
follow
case
infectionreactiv
hbov
occur
two
episod
bal
sampl
fibrosi
associ
cytokin
express
associ
hbov
infect
support
previous
obtain
data
lead
conclus
hbov
colonisationchron
infect
may
least
one
trigger
could
stimul
airway
remodel
howev
could
argu
vivo
resid
airway
epitheli
cell
involv
immun
respons
also
addit
patient
specif
factor
contribut
alter
profibrot
cytokin
profil
address
problem
experi
airliquidinterfac
cultur
human
airway
epitheli
cell
perform
experi
confirm
profibrot
cytokin
express
infect
cell
cultur
hardli
express
mockinfect
cell
reveal
identifi
cytokin
belong
initi
immun
respons
hbov
infect
accord
literatur
two
hbov
protein
seem
influenc
regul
interferon
beta
pathway
data
appear
controversi
upregul
pathway
inhibit
ifnbeta
product
overexpress
simultan
discoveri
hbov
multiplex
method
start
becom
accept
diagnost
tool
consequ
detect
multipl
infect
especi
respiratori
tract
diseas
becom
common
phenomenon
nowaday
multipl
infect
six
pathogen
simultan
present
singl
respiratori
sampl
frequent
misl
research
statement
human
bocaviru
also
occur
asymptomat
patient
harmless
bystand
rather
pathogen
hypothesi
seem
support
fact
hbov
formal
fulfil
koch
modifi
postul
yet
possibl
anim
model
exist
far
also
volunt
transmiss
trial
recommend
base
current
knowledg
contrari
although
cohort
asymptomat
carrier
sever
studi
shown
hbov
induc
clinic
symptom
asymptomat
viral
shed
meanwhil
believ
origin
long
term
shed
acut
infect
persist
virus
recent
confirm
long
term
prospect
cohort
studi
therebi
shown
rate
asymptomat
hbov
infect
similar
rate
rhinoviru
infect
one
would
doubt
rhinovirus
true
pathogen
moreov
hbov
induc
seriou
cytopath
effect
infect
cell
cultur
typic
featur
pathogen
besid
sever
publish
homebrew
pcr
realtim
pcr
review
numer
commerci
assay
luminex
rvpassay
idaho
filmarray
respifind
assay
develop
releas
market
enabl
detect
hbov
clinic
sampl
howev
multiplex
sole
allow
us
detect
viral
dna
respiratori
sampl
without
provid
essenti
inform
activ
replic
infect
underli
current
clinic
episod
requir
laboratori
test
hbov
shed
longer
month
acut
symptomat
phase
proper
diagnost
human
bocaviru
requir
proof
activ
replic
done
either
detect
viremia
peripher
blood
detect
splice
viral
rna
transcript
shown
present
exclus
activ
phase
replic
increas
bodi
evid
show
human
bocaviru
seriou
pathogen
one
hand
associ
acut
respiratori
infect
sometim
life
threaten
complic
hand
also
could
contribut
long
term
diseas
airway
result
lung
carcinoma
lung
fibrosi
therefor
remain
crucial
analyz
longterm
effect
hbov
infect
identifi
mechan
hbov
persist
determin
host
factor
asymptomat
infect
well
test
hypothesi
hbov
could
trigger
develop
lung
cancer
fibrosi
case
proper
diagnost
hbov
requir
attent
need
evalu
regard
interact
respiratori
virus
may
simultan
detect
clinic
episod
